331763-54-3

Basic information

• Product Name: (S)-3-Amino-4-(3-Chlorophenyl)butyric Acid Hydrochloride
• Synonyms: (betaS)-beta-Amino-3-chlorobenzenebutanoic acid hydrochloride
• CAS NO: 331763-54-3
• Molecular Formula: C10H13Cl2NO2
• Molecular Weight: 250.12
• Mol File: 331763-54-3.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: (S)-3-Amino-4-(3-Chlorophenyl)butyric Acid Hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-3-Amino-4-(3-Chlorophenyl)butyric Acid Hydrochloride(331763-54-3)
• EPA Substance Registry System: (S)-3-Amino-4-(3-Chlorophenyl)butyric Acid Hydrochloride(331763-54-3)

Safety Data

• Hazardous Substances Data: 331763-54-3(Hazardous Substances Data)

Usage

Description

(S)-3-Amino-4-(3-Chlorophenyl)butyric Acid Hydrochloride is a chemical compound that belongs to the class of amino acids. It is a derivative of gamma-aminobutyric acid (GABA) and has potential therapeutic applications in the treatment of neurological disorders and psychiatric conditions. (S)-3-Amino-4-(3-Chlorophenyl)butyric Acid Hydrochloride plays a role in neurotransmission and has been studied for its potential as a GABA receptor modulator. Its hydrochloride form indicates that it is a salt, which may have implications for its stability and solubility in aqueous solutions. Research on this compound is ongoing to explore its pharmacological properties and potential therapeutic uses.

Uses

Used in Pharmaceutical Industry:
(S)-3-Amino-4-(3-Chlorophenyl)butyric Acid Hydrochloride is used as a GABA receptor modulator for its potential therapeutic applications in the treatment of neurological disorders and psychiatric conditions. Its role in neurotransmission makes it a promising candidate for the development of new drugs targeting the GABAergic system.
Used in Research and Development:
(S)-3-Amino-4-(3-Chlorophenyl)butyric Acid Hydrochloride is used as a research compound to explore its pharmacological properties and potential therapeutic uses. Ongoing research aims to understand its interactions with GABA receptors and its effects on neurotransmission, which could lead to the development of new treatments for various neurological and psychiatric conditions.